Elicio Historical Financial Ratios
ELTX Stock | 4.88 0.20 3.94% |
Elicio Therapeutics is recently reporting on over 84 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 3.89 or Days Sales Outstanding of 10.59 will help investors to properly organize and evaluate Elicio Therapeutics financial condition quickly.
Elicio |
About Elicio Financial Ratios Analysis
Elicio TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Elicio Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Elicio financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Elicio Therapeutics history.
Elicio Therapeutics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Elicio Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Elicio Therapeutics sales, a figure that is much harder to manipulate than other Elicio Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Elicio Therapeutics dividend as a percentage of Elicio Therapeutics stock price. Elicio Therapeutics dividend yield is a measure of Elicio Therapeutics stock productivity, which can be interpreted as interest rate earned on an Elicio Therapeutics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Elicio Therapeutics. There are two different methods for calculating Elicio Therapeutics invested capital: operating approach and financing approach. Understanding Elicio Therapeutics invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Most ratios from Elicio Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Elicio Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elicio Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Elicio Stock please use our How to Invest in Elicio Therapeutics guide.At this time, Elicio Therapeutics' PTB Ratio is fairly stable compared to the past year. PB Ratio is likely to rise to 3.89 in 2024, whereas Price To Sales Ratio is likely to drop 0.57 in 2024.
2023 | 2024 (projected) | Graham Number | 18.77 | 17.83 | Receivables Turnover | 33.89 | 17.01 |
Elicio Therapeutics fundamentals Correlations
Click cells to compare fundamentals
Elicio Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Elicio Therapeutics fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Ptb Ratio | (1.38) | (0.98) | (0.25) | (0.18) | 3.71 | 3.89 | |
Book Value Per Share | (4.28) | (6.03) | (23.29) | (32.95) | 2.25 | 2.14 | |
Free Cash Flow Yield | (0.2) | (0.35) | (1.3) | (1.25) | (0.78) | (0.74) | |
Operating Cash Flow Per Share | (1.14) | (2.05) | (7.48) | (7.15) | (6.47) | (6.14) | |
Pb Ratio | (1.38) | (0.98) | (0.25) | (0.18) | 3.71 | 3.89 | |
Free Cash Flow Per Share | (1.2) | (2.07) | (7.65) | (7.37) | (6.48) | (6.16) | |
Roic | 0.36 | 0.32 | 0.42 | 0.26 | (3.14) | (2.99) | |
Net Income Per Share | (1.5) | (1.93) | (8.25) | (9.1) | (6.96) | (6.61) | |
Payables Turnover | 2.15 | 1.1 | 0.73 | 0.38 | 0.27 | 0.25 | |
Cash Per Share | 0.84 | 1.84 | 2.9 | 1.99 | 2.55 | 2.42 | |
Pocfratio | (5.16) | (2.87) | (0.79) | (0.82) | (1.29) | (1.35) | |
Pfcf Ratio | (4.91) | (2.84) | (0.77) | (0.8) | (1.29) | (1.35) | |
Days Payables Outstanding | 170.14 | 331.45 | 497.25 | 968.61 | 1.4K | 1.4K | |
Income Quality | 0.76 | 1.06 | 0.91 | 0.79 | 0.93 | 1.55 | |
Ev To Operating Cash Flow | (4.53) | (2.0) | (0.89) | (0.88) | (1.11) | (1.05) | |
Pe Ratio | (3.92) | (3.06) | (0.71) | (0.65) | (1.2) | (1.26) | |
Return On Tangible Assets | (1.39) | (0.8) | (1.78) | (1.24) | (1.3) | (1.36) | |
Ev To Free Cash Flow | (4.3) | (1.98) | (0.87) | (0.86) | (1.1) | (1.05) | |
Earnings Yield | (0.26) | (0.33) | (1.4) | (1.54) | (0.83) | (0.79) | |
Net Debt To E B I T D A | 0.15 | 0.94 | (0.0485) | (0.0563) | 0.18 | 0.17 | |
Current Ratio | 4.15 | 4.67 | 0.55 | 1.56 | 1.67 | 2.78 | |
Tangible Book Value Per Share | (4.28) | (6.03) | (23.29) | (32.95) | 2.25 | 2.14 | |
Graham Number | 12.04 | 16.17 | 65.76 | 82.13 | 18.77 | 17.83 | |
Shareholders Equity Per Share | (4.28) | (6.03) | (23.29) | (32.95) | 2.25 | 2.14 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Elicio Stock Analysis
When running Elicio Therapeutics' price analysis, check to measure Elicio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicio Therapeutics is operating at the current time. Most of Elicio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicio Therapeutics' price. Additionally, you may evaluate how the addition of Elicio Therapeutics to your portfolios can decrease your overall portfolio volatility.